MDXG FY 2017 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$321M+31.1% YoY

Gross Profit

$286M89.0% margin

Operating Income

$46M14.4% margin

Net Income

$65M20.2% margin

EPS (Diluted)

$0.56

Cash Flow

Operating Cash Flow

$63M

Free Cash Flow

$58M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$121M

Total Liabilities

$47M

Stockholders' Equity

$74M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$321M	$245M	+31.1%
Gross Profit	$286M	$213M	+34.5%
Operating Income	$46M	$884,000	+5128.8%
Net Income	$65M	$12M	+440.6%